Elizabeth E Reed sold $250K of Travere Therapeutics (TVTX)

Executed Sep 22 2025, disclosed Sep 24 2025, 2 days later.

Value, as filed

$250K

10,000 sh × $25.00

Executed

Sep 22 2025

the trade date, as filed

Disclosed

Sep 24 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Elizabeth E Reed SVP, GC & CORPORATE SECRETARY profile →

Elizabeth E Reed (SVP, GC & CORPORATE SECRETARY) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $2.2M of TVTX (35,800 sh across 2 lots, as filed), executed Sep 15.

The name

TVTX

Travere Therapeutics, Inc. TVTX · Healthcare · 73 filings in 24 months ticker →

Healthcare · Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Elizabeth E Reed in TVTX

TVTXSALE Travere Therapeutics, Inc. $2.2M
35,800 sh across 2 lots
Exec Sep 15
Filed Sep 17 · 9:32 PM ET TVTXSALE Travere Therapeutics, Inc. $1.0M
22,174 sh across 2 lots
Exec May 4
Filed May 6 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $2.1M
49,941 sh across 3 lots
Exec Apr 14
Filed Apr 15 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $300K
10,000 sh × $30.00
Exec Apr 1
Filed Apr 2 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $281K
10,000 sh × $28.09
Exec Mar 16
Filed Mar 18 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $278K
10,000 sh across 2 lots
Exec Feb 17
Filed Feb 19 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $230K
7,175 sh × $32.12
Exec Feb 3
Filed Feb 3 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $273K
10,000 sh × $27.34
Exec Jan 20
Filed Jan 21 · 5:30 PM ET